Area of research
Epidemiology · Molecular Biology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Gut microbiota and health, Sperm and Testicular Function, and Alcohol Consumption and Health Effects.
Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota.
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease
Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice
Uplift of the Hengduan Mountains on the southeastern margin of the Tibetan Plateau in the late Miocene and its paleoenvironmental impact on hominoid diversity
Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis.
Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2
<i>TP53</i> Mutations Promote Immunogenic Activity in Breast Cancer
YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity
Intestinal fungi contribute to development of alcoholic liver disease
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation
Methods to determine intestinal permeability and bacterial translocation during liver disease
Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice